These findings demonstrate that DHRS4-AS1/miR-224-3p signaling and downstream genes, TP53 and TET1 play important roles in the cancer cell stemness of NSCLC in vitro and in vivo. This evidence concerns the gene DHRS4 and non-small cell lung carcinoma.